Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
Figure 6
(a) Comparison of swollen joint count between iguratimod and placebo groups. (b) Comparison of swollen joint count between iguratimod and other DMARDs (MTX and SASP) groups.
